Bonisolli L, Pontiroli A E, De Pasqua A, Calderara A, Maffi P, Gallus G, Radaelli G, Pozza G
Acta Diabetol Lat. 1985 Oct-Dec;22(4):305-15. doi: 10.1007/BF02624749.
Different prevalences of chlorpropamide alcohol flushing (CPAF) have been reported by different authors in either type I or type II diabetics or in normal subjects and this could be due to different methodological approaches or to different criteria of evaluation of CPAF. Previous studies in small series of patients have also suggested the existence of an association between type I diabetes and the fast acetylator phenotype (AP). The first aim of this study was to find reliable criteria for the assessment of CPAF. The second was to evaluate the prevalence of CPAF and of AP in a large series of type I and type II diabetics; and the third was to evaluate possible associations of CPAF and AP. AP and CPAF were evaluated separately in 256 diabetics (110 with type I and 146 with type II diabetes) and in 183 diabetics (74 with type I and 109 with type II diabetes), respectively. In 156 of these subjects, the two markers were evaluated together. The occurrence of CPAF was studied by subjective and objective assessment and by thermographic recording; CPAF was quantified by the differential value of skin temperature increase [delta T(C-P)] and by the value of differential speed of ascent, expressed in angle-degrees [delta a(C-P)], after treatment with placebo and with chlorpropamide. The fast AP was more frequent in type I than in type II diabetics, was not related to family history of diabetes, sex of the patients, age at onset and duration of diabetes or metabolic control. The most reliable assessment of CPAF was represented by thermographic recording of speed of ascent of skin temperature. CPAF was more frequent in females than in males, more frequent in diabetics than in healthy controls, similarly frequent in type I and in type II diabetes and showed no relationship with family history of diabetes, age at onset, duration of diabetes or metabolic control. An association between fast AP and CPAF was found in type II, but not in type I diabetics: fast acetylators were more frequently CPAF-positive, while slow acetylators were more frequently CPAF-negative. In addition, a linear relationship was found between rate of acetylation and speed of ascent of facial skin temperature after chlorpropamide and alcohol in type II diabetics, not in type I diabetics. The meaning of this association is not clear and deserves further investigations.
不同作者报道了Ⅰ型或Ⅱ型糖尿病患者以及正常受试者中氯磺丙脲酒精潮红(CPAF)的不同患病率,这可能是由于不同的方法学途径或CPAF评估标准不同所致。先前对小样本患者的研究也提示Ⅰ型糖尿病与快速乙酰化表型(AP)之间存在关联。本研究的首要目的是找到评估CPAF的可靠标准。第二个目的是评估一大系列Ⅰ型和Ⅱ型糖尿病患者中CPAF和AP的患病率;第三个目的是评估CPAF和AP之间可能存在的关联。分别对256例糖尿病患者(110例Ⅰ型糖尿病患者和146例Ⅱ型糖尿病患者)和183例糖尿病患者(74例Ⅰ型糖尿病患者和109例Ⅱ型糖尿病患者)进行了AP和CPAF评估。在其中156例受试者中,对这两种标志物进行了联合评估。通过主观和客观评估以及热成像记录研究CPAF的发生情况;在用安慰剂和氯磺丙脲治疗后,通过皮肤温度升高的差值[ΔT(C - P)]以及以角度表示的上升速度差值[Δa(C - P)]对CPAF进行量化。快速AP在Ⅰ型糖尿病患者中比在Ⅱ型糖尿病患者中更常见,与糖尿病家族史、患者性别、发病年龄、糖尿病病程或代谢控制无关。对CPAF最可靠的评估是以皮肤温度上升速度的热成像记录来表示。CPAF在女性中比在男性中更常见,在糖尿病患者中比在健康对照中更常见,在Ⅰ型和Ⅱ型糖尿病中同样常见,且与糖尿病家族史、发病年龄、糖尿病病程或代谢控制无关。在Ⅱ型糖尿病患者中发现快速AP与CPAF之间存在关联,但在Ⅰ型糖尿病患者中未发现:快速乙酰化者CPAF阳性更为常见,而慢速乙酰化者CPAF阴性更为常见。此外,在Ⅱ型糖尿病患者中发现了氯磺丙脲和酒精后乙酰化速率与面部皮肤温度上升速度之间存在线性关系,而在Ⅰ型糖尿病患者中未发现。这种关联的意义尚不清楚,值得进一步研究。